Tharimmune Raises $540M to Build Canton Coin Treasury Strategy
Tharimmune raised $540 million in a private placement to pivot into a digital asset treasury strategy centered on canton coin (CC).Summary
Nasdaq-listed Tharimmune (THAR), a nanocap biotech firm, announced it raised approximately $540 million in a private placement led by DRW and Liberty City Ventures. This significant capital raise signals the company's pivot toward a digital asset treasury (DAT) strategy focused on canton coin (CC), the utility token for the institutional finance-focused Canton Network. The stock gained about 30% on the news. The round saw participation from major crypto and traditional finance entities, including ARK Invest, Kraken, and Polychain Capital, making Tharimmune the first publicly traded company directly supported by the Canton Foundation. Proceeds will fund the acquisition of canton coin, operational costs, and running validator nodes on the Canton Network. While the biotech operations continue, the firm appointed new leadership to spearhead the treasury initiative.
(Source：CoinDesk)